A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adults.
Condition:   Pneumococcal Disease Interventions:   Other: Low dose multivalent pneumococcal conjugate vaccine formulation A;   Other: Low dose multivalent pneumococcal conjugate vaccine formulation B;   Biological: Low dose of multivalent pneumococcal conjugate vaccine control;   Biological: Standard dose multivalent pneumococcal conjugate va ccine control Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2023 Category: Research Source Type: clinical trials

A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adults.
Condition:   Pneumococcal Disease Interventions:   Other: Low dose multivalent pneumococcal conjugate vaccine formulation A;   Other: Low dose multivalent pneumococcal conjugate vaccine formulation B;   Biological: Low dose of multivalent pneumococcal conjugate vaccine control;   Biological: Standard dose multivalent pneumococcal conjugate va ccine control Sponsor:   Pfizer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2023 Category: Research Source Type: clinical trials